Catalyst Wire Dossier Catalyst Wire Dossier
EMA approval · 2026-07-21

EMA Authorised: Tolucombi (telmisartan;hydrochlorothiazide) — Krka, d.d., Novo mesto

View source ↗

Summary

Authorised combination medicine Tolucombi (telmisartan and hydrochlorothiazide) for hypertension by Krka, d.d., Novo mesto.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • Tolucombi (telmisartan; hydrochlorothiazide)

Snippet

Status: Authorised. Therapeutic area: Hypertension. MAH: Krka, d.d., Novo mesto. Decision date: 16/07/2026